IRCT20200105046010N2招募中未知
In- Vivo Bioequivalence study of Eplerenone tablet 50mg Anourayhan (Alderon 50mg) with brand drugs (Inspra 50mg, Pfizer, Gremany) in Iranian healthy volunteers
Aburayhan Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health(liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Pirfenidone tablet 200 mg Arang Pharma with brand drug (PIRFENEX® 200mg, Cipla, India)IRCT20200105046010N61Arang Pharm Co.24
招募中
不适用
In-vivo Bioequivalence Test of Empagliflozin tablets with brand drug (JARDIANCE® 25 mg, Boehringer Ingelheim , Germany)Bio equivalence test.IRCT20200105046010N49Pars Darou Pharm. Co.24
招募中
不适用
In-vivo Bioequivalence Test of Abiraterone tablet 500 mg Actero Middle East with brand drug (ZYTIGA® 500 mg, Janssen Biotech, Germany)Bio equivalence test.IRCT20200105046010N57Actero middle east Pharm Co.24
招募中
不适用
In-vivo Bioequivalence Test of Abiraterone tablets with brand drug (ZYTIGA® 500 mg, Janssen Biotech, Germany)Bio equivalence test.IRCT20200105046010N55anoalvand Pharmaceutical Co24
招募中
不适用
In-vivo Bioequivalence Test of Abiraterone tablet 250 mg Sobhan Oncology with brand drug (ZYTIGA® 500 mg, Janssen Biotech, Germany)IRCT20200105046010N59Sobhan Oncology Pharmaceutical CO.24